Editorial: acute severe autoimmune hepatitis-a diagnostic and therapeutic dilemma
- PMID: 35689316
- DOI: 10.1111/apt.16981
Editorial: acute severe autoimmune hepatitis-a diagnostic and therapeutic dilemma
Comment on
-
Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study.Aliment Pharmacol Ther. 2022 Jul;56(1):131-143. doi: 10.1111/apt.16926. Epub 2022 Apr 25. Aliment Pharmacol Ther. 2022. PMID: 35470447 Free PMC article.
References
REFERENCES
-
- Wang G, Tanaka A, Zhao H, Jia J, Ma X, Harada K, et al. The Asian Pacific Association for the Study of the Liver clinical practice guidance: the diagnosis and management of patients with autoimmune hepatitis. Hepatol Int. 2021;15:223-57.
-
- Rahim MN, Liberal R, Miquel R, Heaton ND, Heneghan MA. Acute severe autoimmune hepatitis: corticosteroids or liver transplantation? Liver Transpl. 2019;25:946-59.
-
- Téllez L, Sánchez Rodríguez E, Rodríguez de Santiago E, Llovet L, Gómez-Outomuro A, Díaz-Fontenla F, et al. Early predictors of corticosteroid response in acute severe autoimmune hepatitis: a nationwide multicenter study. Aliment Pharmacol Ther. 2022;56:131-143.
-
- De Martin E, Coilly A, Chazouillères O, et al. Early liver transplantation for corticosteroid non-responders with acute severe autoimmune hepatitis: the SURFASA score. J Hepatol. 2021;74:1325-34.
-
- Lohse AW, Sebode M, Bhathal PS, Clouston AD, Dienes HP, Jain D, et al. Results of a workshop on AIH histology hosted by the European Reference Network on Hepatological Diseases and the European Society of Pathology. Liver Int. 2022;42:1058-69.